BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2009
View Archived Issues
Bevacizumab shows efficacy in patients with alkylator-refractory anaplastic astrocytoma
Read More
Phase I trial of EC-0489 for refractory or metastatic solid tumors begins
Read More
Schering-Plough reviews first quarter activities
Read More
siRNA-based therapy for pachyonychia congenita shows promise in phase Ib trial
Read More
Synthetic peptide ACT-1 enhances corneal wound healing in rats
Read More
Triamcinolone affects biomarkers of axonal damage and glial activity in MS patients
Read More
MacuSight's proprietary sirolimus ocular formulation shows promising pharmacokinetic profile
Read More
FDA approves Nerviano's IND to initiate phase I clinical trial of cancer drug PLK-1
Read More
Alkermes commences new ALKS-33 trials
Read More
Merck KGaA presents novel TGF-beta inhibitors for cancer treatment
Read More
Taiho claims novel retinoid RARalpha agonists as antitumor agents
Read More
Azor receives FDA approval as first-line high blood pressure treatment
Read More
Sanofi-aventis claims histamine H3 receptor inverse agonists for the treatment of sleep disorders
Read More
Takeda discloses retinol binding protein 4 lowering agents for the treatment of diabetes
Read More
Novel Na+/K+-ATPase inhibitors presented by Sigma-Tau for heart failure and hypertension
Read More
Data on MedImmune anticancer monoclonal antibodies MEDI-573, MEDI-3617 presented
Read More
LiPlasome describes activity of liposomal formulations of cisplatin, oxaliplatin
Read More
Cellerant Therapeutics doses first patient in a phase I CLT-008 trial
Read More
Nerviano Medical Sciences discloses novel anticancer agents under preclinical evaluation
Read More
Addrenex expands pipeline by licensing new drug to treat narcolepsy
Read More
Vivus announces the initiation of an open-label safety study for avanafil in ED
Read More
OSI provides update on diabetes and obesity programs
Read More
NIAID awards Dynavax 2-year grant for TLR inhibitors in skin diseases
Read More
Pozen to file NDA with the FDA for antiinflammatory drug PN-400 in mid-2009
Read More
The Medicines Company discontinues phase III CHAMPION clinical trials of cangrelor
Read More
FDA approves UCB's pegylated anti-TNF Cimzia for rheumatoid arthritis
Read More
